BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12850839)

  • 1. Human platelet 20S proteasome: inhibition of its chymotrypsin-like activity and identification of the proteasome activator PA28. A preliminary report.
    Ostrowska H; Ostrowska JK; Worowski K; Radziwon P
    Platelets; 2003 May; 14(3):151-7. PubMed ID: 12850839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
    Ostrowska H; Wojcik C; Omura S; Worowski K
    Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin A and chymotrypsin-like activity of the proteasome in human blood platelets.
    Ostrowska H; Wójcik C; Worowski K
    Folia Histochem Cytobiol; 1999; 37(2):153-4. PubMed ID: 10353004
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
    Stein RL; Melandri F; Dick L
    Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome.
    Ostrowska H; Wójcik C; Wilk S; Omura S; Kozlowski L; Stoklosa T; Worowski K; Radziwon P
    Int J Biochem Cell Biol; 2000 Jul; 32(7):747-57. PubMed ID: 10856705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
    McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
    Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
    Zhang XM; Lin H; Chen C; Chen BD
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative resistance of the 20S and 26S proteasome to oxidative stress.
    Reinheckel T; Sitte N; Ullrich O; Kuckelkorn U; Davies KJ; Grune T
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):637-42. PubMed ID: 9794805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors.
    Demasi M; Shringarpure R; Davies KJ
    Arch Biochem Biophys; 2001 May; 389(2):254-63. PubMed ID: 11339815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.
    García-Echeverría C; Imbach P; France D; Fürst P; Lang M; Noorani AM; Scholz D; Zimmermann J; Furet P
    Bioorg Med Chem Lett; 2001 May; 11(10):1317-9. PubMed ID: 11392545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Leishmania chagasi proteasome: role in promastigotes growth and amastigotes survival within murine macrophages.
    Silva-Jardim I; Horta MF; Ramalho-Pinto FJ
    Acta Trop; 2004 Jul; 91(2):121-30. PubMed ID: 15234661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural investigation of proteasome inhibition.
    Ditzel L; Stock D; Löwe J
    Biol Chem; 1997; 378(3-4):239-47. PubMed ID: 9165077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90.
    Conconi M; Petropoulos I; Emod I; Turlin E; Biville F; Friguet B
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):407-15. PubMed ID: 9657982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the proteasome activator PA28 is required for proteasome activation.
    Li N; Lerea KM; Etlinger JD
    Biochem Biophys Res Commun; 1996 Aug; 225(3):855-60. PubMed ID: 8780702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown.
    Kisselev AF; Akopian TN; Castillo V; Goldberg AL
    Mol Cell; 1999 Sep; 4(3):395-402. PubMed ID: 10518220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pH.
    Figueiredo-Pereira ME; Chen WE; Yuan HM; Wilk S
    Arch Biochem Biophys; 1995 Feb; 317(1):69-78. PubMed ID: 7872805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the active site of human multicatalytic proteinase.
    Mason RW
    Biochem J; 1990 Jan; 265(2):479-84. PubMed ID: 2302179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the chymotrypsin-like activity of the 20S proteasome by intracellular redox status: effects of glutathione peroxidase-1 overexpression and antioxidant drugs.
    Kretz-Remy C; Arrigo AP
    Biol Chem; 2003 Apr; 384(4):589-95. PubMed ID: 12751788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic properties of 26 S and 20 S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities.
    Reidlinger J; Pike AM; Savory PJ; Murray RZ; Rivett AJ
    J Biol Chem; 1997 Oct; 272(40):24899-905. PubMed ID: 9312091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the PA28alpha-20S proteasome interaction by a peptidyl alcohol.
    Wilk S; Chen WE; Magnusson RP
    Arch Biochem Biophys; 1999 Feb; 362(2):283-90. PubMed ID: 9989937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.